Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

US Supreme Court hears arguments in abortion pill case

U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.

France 24

Are "Roe-Bots" the Future of Abortion Access?

As the Supreme Court heard arguments in a case that could severely curtail medication abortion nationwide, one organization showed that reproductive healthcare is here to stay—no matter what.

Marie Claire

Supreme Court Leans Towards Upholding FDA Abortion Drug Regulations

Supreme Court hears arguments on FDA regulations for mifepristone, a key abortion drug, with implications for nationwide access.

Top News

From analysis to the latest developments in health,
read the most diverse news in one place.

Clashing convictions mark protests as US supreme court weighs abortion pill

Hearing on mifepristone most consequential abortion-related case since overturning of Roe v Wade nearly two years ago

The Guardian - US

Why a 19th-century law matters in the Supreme Court abortion pill fight

The 1873 law banned the mailing of materials that were deemed "obscene."

Axios

US supreme court abortion pill hearing: key takeaways

Justices appear skeptical of arguments against mifepristone as pharmaceutical industry considers case existential threat

The Guardian - US

Supreme Court Grapples With FDA's Oversight Of Abortion Pill Amid Legal Battle

Both conservative and liberal justices questioned whether the plaintiffs could show direct injury merely because they object to abortion.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

Supreme Court seems doubtful of challenge to abortion pill

At issue in the case is more than abortion rights. It's the entire structure of the FDA's regulatory power to approve drugs and continually evaluate their safety.

WEKU

Supreme Court seems unlikely to restrict access to abortion pill

Medication-induced abortions account for two-thirds of all abortions.

Axios

Abortion pill ruling could be "catastrophic" for new drug development

"It would be a catastrophic event."

Axios

Mifepristone in the Supreme Court—Comments on Oral Argument (Updated)

Live commentary on the Supreme Court oral argument in FDA v. Alliance for Hippocratic Medicine

Reason

Greater Protections for Assange

Plus: Abortion pill case, another fatal subway crime, China's Cultural Revolution, and more...

Reason

Supreme Court sounds unlikely to limit medication abortion access - Roll Call

The Supreme Court appeared skeptical Tuesday of a lower court ruling that would restrict access to the medication abortion drug mifepristone.

Roll Call

Can Emergency Room Doctors Sue the FDA for Failing to Regulate Mifepristone More Aggressively?

The threshold issue in today's oral argument is Article III standing, and that issue should be determinative.

Reason

Get all your
news in one place.

100's of premium titles.
One news app.

Axios

How the Supreme Court could determine abortion pill access

The court's decision further curtails abortion access nearly two years after overturning Roe v. Wade.

WEKU

Baltimore's Francis Scott Key Bridge collapses; SCOTUS takes on abortion pill case

A vital Baltimore bridge collapsed overnight after a ship crashed into it. How the Supreme Court's ruling in the abortion pill case could affect other drugs.

The Guardian - UK

First Thing: Maryland declares state of emergency after Baltimore bridge collapse

Rescue operations under way after at least seven vehicles fell into the water. Plus, UN security council demands immediate ceasefire in Gaza

Top News

US Lawmaker Questions FDA Inspection Of Neuralink By Musk

US lawmaker seeks answers on FDA inspection of Elon Musk's Neuralink, raising concerns about safety and compliance.

Get all your
news in one place.

100's of premium titles.
One news app.

Top News

Supreme Court To Decide High-Stakes Abortion Pill Case

The Supreme Court's upcoming decision on mifepristone's approval process could have significant implications for reproductive rights and healthcare access ...

The Guardian - US

US supreme court seems skeptical of arguments against abortion drug mifepristone

Decision in anti-abortion doctors’ favor would apply across US and would likely make the drug more difficult to acquire

The Texas Tribune

U.S. Supreme Court takes up Texas case challenging abortion pill access

A majority of Supreme Court justices seemed open to keeping mifepristone, a common abortion-inducing drug, on the market despite a Texas ruling revoking its FDA approval.

Axios

SCOTUS abortion pill hearing puts FDA discretion on trial

A ruling against expanded mifepristone access could set a precedent for courts to substitute their own conclusions for agency decisions.

WEKU

A Supreme Court abortion pill case with potential consequences for every other drug

At issue is the FDA's regulatory power to approve drugs and continually evaluate their safety — a system that until now has been widely viewed as the gold standard for both safety and innovation

Top News

Supreme Court Abortion Case Impacting Access To Medication

Supreme Court case on mifepristone access in abortion with potential nationwide healthcare implications.

Ballotpedia

Robe & Gavel: SCOTUS concludes March 2024 sitting

Welcome to the March 25 edition of Robe & Gavel, Ballotpedia’s newsletter about the Supreme Court of the United States (SCOTUS) and other judicial happenings around the U.S.

1 … 95 96 97 98

People

Ketanji Brown Jackson

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

the Food and Drug Administration

208 stories

the 5th Circuit

171 stories

the US Court of Appeals

143 stories

the US District Court

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.